014950 Stock Chart & Stats
₩4460.00
₩215.00(5.06%)
―
--
Day’s Range― - ―
52-Week Range₩3,705.00 - ₩25,050.00
Previous CloseN/A
VolumeN/A
Average Volume (3M)3.23M
Market Cap
₩42.73B
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)11.9
Beta0.62
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding10,067,588
10 Day Avg. Volume2,431,987
30 Day Avg. Volume3,231,355
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
014950 FAQ
What was Samik Pharm Co., Ltd.’s price range in the past 12 months?
Samik Pharm Co., Ltd. lowest stock price was ₩3705.00 and its highest was ₩25050.00 in the past 12 months.
What is Samik Pharm Co., Ltd.’s market cap?
Samik Pharm Co., Ltd.’s market cap is ₩42.73B.
When is Samik Pharm Co., Ltd.’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Samik Pharm Co., Ltd.’s earnings last quarter?
Samik Pharm Co., Ltd. released its earnings results on May 15, 2026. The company reported ₩134.723 earnings per share for the quarter, beating the consensus estimate of N/A by ₩134.723.
Is Samik Pharm Co., Ltd. overvalued?
According to Wall Street analysts Samik Pharm Co., Ltd.’s price is currently Undervalued.
Does Samik Pharm Co., Ltd. pay dividends?
Samik Pharm Co., Ltd. does not currently pay dividends.
What is Samik Pharm Co., Ltd.’s EPS estimate?
Samik Pharm Co., Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Samik Pharm Co., Ltd. have?
Samik Pharm Co., Ltd. has 10,067,588 shares outstanding.
What happened to Samik Pharm Co., Ltd.’s price movement after its last earnings report?
Samik Pharm Co., Ltd. reported an EPS of ₩134.723 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went down -5.521%.
Which hedge fund is a major shareholder of Samik Pharm Co., Ltd.?
Currently, no hedge funds are holding shares in KR:014950
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Yuyu Pharma, Inc.
―
HLB GLOBAL Co., Ltd.
―
SINIL PHARMACEUTICAL Co., Ltd.
―
Hwail Pharmaceutical Co., Ltd.
―
PanGen Biotech, Inc.
―